In This Article:
The European market recently faced a downturn, with major stock indexes declining following the announcement of potential tariffs on EU goods by the U.S. President. Amidst this backdrop, investors are increasingly looking towards alternative investment opportunities that can offer resilience and growth potential. Penny stocks, despite their somewhat outdated name, represent smaller or newer companies that might provide surprising value when backed by solid financials. In this article, we explore three such penny stocks in Europe that combine strong balance sheets with promising prospects for investors seeking hidden value in quality companies.
Top 10 Penny Stocks In Europe
Name | Share Price | Market Cap | Financial Health Rating |
Bredband2 i Skandinavien (OM:BRE2) | SEK2.315 | SEK2.22B | ★★★★☆☆ |
Transferator (NGM:TRAN A) | SEK2.00 | SEK196.5M | ★★★★★☆ |
Angler Gaming (NGM:ANGL) | SEK3.71 | SEK278.19M | ★★★★★★ |
Hifab Group (OM:HIFA B) | SEK3.66 | SEK222.67M | ★★★★★★ |
Abak (WSE:ABK) | PLN4.40 | PLN11.86M | ★★★★★★ |
Cellularline (BIT:CELL) | €2.90 | €61.17M | ★★★★★☆ |
Netgem (ENXTPA:ALNTG) | €0.958 | €32.08M | ★★★★★★ |
Fondia Oyj (HLSE:FONDIA) | €4.69 | €17.54M | ★★★★★★ |
Mistral Iberia Real Estate SOCIMI (BME:YMIB) | €1.01 | €22M | ★★★★★☆ |
Deceuninck (ENXTBR:DECB) | €2.20 | €303.74M | ★★★★★★ |
Click here to see the full list of 445 stocks from our European Penny Stocks screener.
Here we highlight a subset of our preferred stocks from the screener.
Lhyfe
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Lhyfe SA produces and supplies renewable green hydrogen for mobility and industry markets, with a market cap of €156.53 million.
Operations: The company generates revenue from its Oil & Gas - Exploration & Production segment, amounting to €5.10 million.
Market Cap: €156.53M
Lhyfe SA, with a market cap of €156.53 million, reported revenue of €5.10 million for the full year ending December 2024, reflecting growth from €1.32 million the previous year. Despite this increase in sales, Lhyfe remains unprofitable with a net loss of €29.09 million and a negative return on equity of -40.72%. The company's share price has been highly volatile over the past three months; however, shareholders have not faced significant dilution recently. While Lhyfe's short-term assets exceed its short-term liabilities, they do not cover long-term liabilities entirely. The company’s debt to equity ratio has improved over five years to 69.3%.
-
Unlock comprehensive insights into our analysis of Lhyfe stock in this financial health report.
-
Gain insights into Lhyfe's future direction by reviewing our growth report.
Nexam Chemical Holding
Simply Wall St Financial Health Rating: ★★★★☆☆